jcp Videos

Videos

Videos

Becoming a Patient Advocate: Tips for Getting Started

04/12/2024

Featuring Rose Gerber, MS

Patient advocate and cancer survivor Rose Gerber shares her experience in cancer patient advocacy and offers tips for those who wish to become advocates.

Patient advocate and cancer...

04/12/2024

Journal of Clinical Pathways

Conference Coverage

Comparing BTK Inhibitors for Frontline Chronic Lymphocytic Leukemia Treatment

04/10/2024

Featuring John Allan, MD

John Allan, MD, compares the use of different BTK inhibitors for the treatment of CLL in a frontline setting and discusses whether there is an optimal drug regimen to use among patients with CLL.

John Allan, MD, compares the use...

04/10/2024

Lymphoma, Leukemia & Myeloma Network

Videos

How Health Care Stakeholders in Oncology Can Prepare for and Manage Drug Shortages

04/08/2024

Featuring Erin Fox, PharmD

Erin Fox, PharmD, shares steps health care stakeholders can take to mitigate the impact of drug shortages on cancer care.

Erin Fox, PharmD, shares steps...

04/08/2024

Journal of Clinical Pathways

Videos

Best Practices in Care Team Communication Technology: Updates From NCCN 2024

04/06/2024

Featuring Robert Stillman, MA, RN

Featuring Robert Stillman, MA, RN ...

Robert Stillman, MA, RN, describes some of the latest innovations in health care communications technology and how providers can use these tools to improve their practices and provide value-based care.

Robert Stillman, MA, RN,...

04/06/2024

Journal of Clinical Pathways

Videos

An Overview of the Benefits and Challenges of Providing Outpatient Oncology Care

04/06/2024

Featuring Anna Halpern, MD

Anna Halpern, MD, discusses her National Comprehensive Cancer Network annual conference session on how to balance inpatient and outpatient oncology care.

Anna Halpern, MD, discusses her...

04/06/2024

Journal of Clinical Pathways

Videos

Oncology Legislative Updates and Predictions From Capitol Hill: COA 2024

04/05/2024

Featuring Ted Okon, MBA

Ted Okon, MBA, discusses some of the latest pressing issues in Washington that are impacting oncology stakeholders, particularly in the community oncology setting.

Ted Okon, MBA, discusses some of...

04/05/2024

Journal of Clinical Pathways

Videos

Recent Advancements in Myeloma Treatment Changing the Standard of Care

04/04/2024

Featuring Hamza Hashmi, MD

Hamza Hashmi, MD, Memorial Sloan Kettering Cancer Center, shares insights on recent advancements in myeloma treatment and gives a preview of his session on managing myeloma at the 2024 Community Oncology Conference.

Hamza Hashmi, MD, Memorial Sloan...

04/04/2024

Journal of Clinical Pathways

Videos

Innovations in Oncology Pathways at the Community Oncology Conference

04/03/2024

Featuring Edward Arrowsmith, MD

Featuring Edward Arrowsmith, MD ...

Edward Arrowsmith, MD, provides insight into the development of clinical pathways at OneOncology and shares highlights from the 2024 Community Oncology Conference.

Edward Arrowsmith, MD, provides...

04/03/2024

Journal of Clinical Pathways

Videos

Amivantamab Plus Chemotherapy Improved Treatment Outcomes Among Patients With Advanced EGFR-Mutated Non-Small Cell Lung Cancer

04/02/2024

Featuring Alex Spira, MD, PhD, FACP

Featuring Alex Spira, MD, PhD, FACP ...

Alexander Spira, MD, PhD, FACP, discussed post-progression results from the phase 3 MARIPOSA-2 trial, as presented at the European Lung Cancer Congress 2024.

Alexander Spira, MD, PhD, FACP,...

04/02/2024

Oncology

Breaking Down Health Care

The Government and Health Care: A Volatile or Necessary Mix? (Part I)

04/01/2024

Featuring Michael Kolodziej, MD, and John Hennessy, MBA

Featuring Michael Kolodziej, MD, and ...

In this Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, cover the US federal government’s role in health care—Medicare, Medicaid, and the Affordable Care Act. They discuss the benefits, challenges, and...

In this Breaking Down Health...

04/01/2024

Cancer Care Business Exchange

Current Issue

October 2024

Volume 10

Issue 5

Current Issue

Issue Archive

Special Reports

Sponsored

JCP Special Report

The Value of Tissue-Based Genomic Profiling in Oncology

09/17/2024

Innovations in precision oncology have helped healthcare providers to create more personalized treatment plans and improve patient outcomes. View this special report to learn more.

Innovations in precision...

09/17/2024

Journal of Clinical Pathways

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee ;

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Robin T. Zon , MD, FACP, FASCO;

Gordon Kuntz ;

Winston Wong , PharmD;

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan ;

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Sponsored

Special Report

Navigating the Patient Journey for Unresectable Stage III Non-Small Cell Lung Cancer

09/16/2021

.ryan-test { display: none; } .body-content h3 { font-size: 18px; line-height: 18px; color: #000000; font-weight: 600px; } .related-content { display: none; } .body-content div > div:nth-of-type(3) .paragraph > h3 >...

.ryan-test { display:...

09/16/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Videos

Current Issue

Special Reports

Subscribe

Specialties

Events

Year Round Education

HMP Global Products